(Q46120171)

English

Incidence of sinusoidal obstruction syndrome following Mylotarg (gemtuzumab ozogamicin): a prospective observational study of 482 patients in routine clinical practice

scientific article published on 5 March 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23460018

Incidence of sinusoidal obstruction syndrome following Mylotarg (gemtuzumab ozogamicin): a prospective observational study of 482 patients in routine clinical practice (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23460018

Martin S. Tallman

1

object named as

Martin S Tallman

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

author name string

George B McDonald

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23460018

Laurie D DeLeve

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23460018

Maria R Baer

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23460018

Michael N Cook

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23460018

G Jay Graepel

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23460018

Carl Kollmer

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23460018

publication date

5 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23460018

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23460018

97

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23460018

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23460018

456-464

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23460018

Drug therapy for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1275-2

21 January 2018

Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1275-2

21 January 2018

Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1275-2

21 January 2018

Bone marrow progenitor cells repair rat hepatic sinusoidal endothelial cells after liver injury

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1275-2

21 January 2018

Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1275-2

21 January 2018

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1275-2

21 January 2018

Veno-occlusive disease of the liver

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1275-2

21 January 2018

A problem-oriented approach to liver disease in oncology patients

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1275-2

21 January 2018

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1275-2

21 January 2018

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1275-2

21 January 2018

Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1275-2

21 January 2018

The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1275-2

21 January 2018

Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23460018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23460018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The biology of acute myeloblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23460018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project

1 reference

https://pubmed.ncbi.nlm.nih.gov/23460018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of hepatic sinusoidal obstruction syndrome following treatment with gemtuzumab ozogamicin (Mylotarg).

1 reference

https://pubmed.ncbi.nlm.nih.gov/23460018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/23460018

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-013-1275-2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23460018

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23460018

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46120171&oldid=2207650595"